Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

about

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

Item

http://www.wikidata.org/entity/Q47552415

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@en

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@nl

type

Item

label

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@en

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@nl

prefLabel

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@en

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@nl

P1476

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

@en

P2093

Beatriz Santos-Carballal

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery

Chitin and chitosan: Properties and applications

Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells

Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis.

Chitin and chitosan preparation from marine sources. Structure, properties and applications.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Nanocarriers for intravenous injection--the long hard road to the market.

Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.

Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages.

Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.

P31

scholarly article

P356

10.3390/MA11010122

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sally-Ann Cryan

Elena Fernández Fernández

P577

2018-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29342838

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

5793620

http://www.w3.org/2001/XMLSchema#string